克隆病在我国的发病率有上升趋势,本病后期可出现多种严重并发症,其临床处理颇为棘手,及时选择有效药物治疗,缓解症状,稳定病情,减少并发症的发生是克隆病临床治疗的关键。颇得斯安(pentasa)为5-氨基水杨酸的缓释制剂,其释放不受大肠菌群、肠内 pH 值等的影响,对溃疡性 Crohn’s disease in our country the incidence of an upward trend in the late stage of the disease can occur a variety of serious complications, the clinical treatment is quite difficult, timely and effective drug treatment to relieve symptoms, stabilize the condition and reduce complications of Crohn’s disease clinical The key to treatment. Pentasan (pentasa) is a 5-aminosalicylic acid sustained-release preparation, its release is not affected by coliform bacteria, intestinal pH, etc., on ulceration